
www.rsisinternational.org
INTERNATIONAL JOURNAL OF LATEST TECHNOLOGY IN ENGINEERING,
MANAGEMENT & APPLIED SCIENCE (IJLTEMAS)
ISSN 2278-2540 | DOI: 10.51583/IJLTEMAS | Volume XV, Issue IV, April 2026
Agentic AI–Driven Disease Prediction for Smart Hospital Systems
Dr. Gopal Pardesi, Sakshi Said, Krishna Ramchandani, Sakshi Vaidya, Harsh Mishra
Dept. of Information Technology Thadomal Shahani Engineering College Mumbai, India
DOI:
https://doi.org/10.51583/IJLTEMAS.2026.150400101
Received: 22 April 2026; Accepted: 27 April 2026; Published: 19 May 2026
ABSTRACT
Traditional Hospital Management Systems (HMS) primarily serve administrative and record-keeping functions
but lack any form of autonomous clinical intelligence. With the growing complexity of patient data, healthcare
institutions increasingly require systems capable of proactive decision support, early disease detection, and
dynamic patient monitoring. This paper presents IntelliHMS 2.0, an innovative hospital management ecosystem
enhanced with Agentic AI, a new paradigm where autonomous, goal-driven AI agents operate collaboratively
to perform multi-step reasoning, analyze multi-modal patient data, and provide real-time disease prediction.
Unlike traditional Machine Learning models that perform static onetime predictions, Agentic AI systems
autonomously retrieve data, interpret clinical signals, reason over medical guidelines, generate insights, and
trigger appropriate actions. IntelliHMS 2.0 integrates multiple specialized AI agents—including a Data
Retrieval Agent, Disease Prediction Agent, Clinical Reasoning Agent, Monitoring Agent, and Explainability
Agent—to create a fully autonomous predictive workflow. Using cloud-based microservices and secure API-
driven architecture, the system ensures scalability, reliability, and continuous adaptation to patient conditions.
By transforming disease prediction from a single-step model into a selfdirected, autonomous diagnostic
pipeline, this system significantly improves early risk detection, enhances clinical decision-making, and
streamlines overall hospital operations. This research highlights the potential of Agentic AI to revolutionize
modern healthcare systems, enabling proactive, intelligent, and adaptive care delivery.
INTRODUCTION
The adoption of digital technologies in healthcare has significantly accelerated in recent years, enabling hospitals
to depend on Hospital Management Systems (HMS) for managing patient records, appointments, billing, and
administrative workflows. However, traditional HMS platforms primarily function as data
storage and retrieval systems, offering limited clinical intelligence or autonomous decision-support capabilities.
As a result, early detection of diseases still relies heavily on manual evaluation and clinician expertise, which
can delay diagnosis and negatively impact patient outcomes, Recent advancements in Agentic Artificial
Intelligence (AI) have demonstrated strong potential in transforming clinical workflows by enabling
autonomous data analysis, multi-step reasoning, and intelligent health monitoring. Studies show that Agentic
AI systems—powered by autonomous, goal-driven agents—can dynamically gather patient data, interpret
symptoms, and evaluate disease risk across multiple chronic conditions such as cardiovascular disorders,
diabetes, and metabolic syndromes [2][3]. Unlike traditional Machine Learning models, which generate static
predictions, Agentic AI agents continuously update their assessments based on real-time vitals, laboratory
findings, and Electronic Health Record (EHR) changes, enabling more accurate and timely diagnostic insights
[4][7]. Systematic reviews further highlight that autonomous agents integrated with EHR systems significantly
enhance proactive healthcare delivery by supporting continuous monitoring and adaptive decision-making
[5][6].
This research proposes an enhanced HMS that incorporates Agentic AI–driven disease prediction and
autonomous reasoning directly into routine hospital workflows. By embedding intelligent agents within the
HMS, healthcare providers can access real-time, self-updating risk assessments, prioritize high-risk patients
earlier, and make faster, more informed clinical decisions. The goal is to transition from a reactive treatment